Browse > Article

Binding Mode Studies of Indenoisoquinoline Analogues into Human Topoisomerase I-DNA Complex Using Flexible Docking  

Park, In-Seon (College of Pharmacy and Division of Life and Pharmaceutical Sciences, Ewha Womans University)
Kim, Bo-Yeon (College of Pharmacy and Division of Life and Pharmaceutical Sciences, Ewha Womans University)
Kim, Choon-Mi (College of Pharmacy and Division of Life and Pharmaceutical Sciences, Ewha Womans University)
Choi, Sun (College of Pharmacy and Division of Life and Pharmaceutical Sciences, Ewha Womans University)
Publication Information
YAKHAK HOEJI / v.53, no.4, 2009 , pp. 228-234 More about this Journal
Abstract
Topoisomerase I (Topo I) participates in the DNA replication, transcription, and repair. Binding of Topo I inhibitor to the Topo I-DNA cleavage complex forms stabilized ternary complex which blocks DNA religation and ultimately causes cell death. Camptothecin (CPT) and its derivatives have been among the most effective anticancer drugs by inhibition of topo I. However, efforts to synthesize non-CPT drugs have been actively going on because the CPT derivatives have several limitations such as poor solubility, short half-life, and side effects. As an indenoisoquinoline, NSC314622 is not as potent as CPT, but its chemical stability and slower reversibility of the cleavage complex made it a good lead compound. Recently, a series of indenoisoquinoline analogues were synthesized with substituted dimethoxy or methylenedioxy on the aromatic ring and alkylamino on the lactam nitrogen. Some of them showed quite good Topo I inhibitory activity. Using the computer docking program, Surflex-Dock, indenoisoquinoline analogues were docked into the human Topo I-DNA cleavable complex. The docking results showed that the compounds with activity better than NSC314622 intercalated between the -1 and +1 base pairs at the cleavage site, but those with little or no activities did not appear to intercalate. These results could be useful to design new Topo I inhibitors improved than CPT.
Keywords
topoisomerase I-DNA complex; indenoisoquinoline; docking; binding modes;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Krogh, B. O. and Shuman, S. : Catalytic mechanism of DNA topoisomerase IB. Mol. Cell 5, 1035 (2000)   DOI   ScienceOn
2 Liu, L. F., Desai, S. D., Li, T. K., Mao, Y., Sun, M. and Sim, S. P. : Mechanism of action of camptothecin. Annals of the New York Academy of Sciences 922, 1 (2000)   PUBMED
3 Strumberg, D., Pommier, Y., Paull, K., Jayaraman, M., Nagafuji, P. and Cushman, M. : Synthesis of cytotoxic indenoisoquinoline topoisomerase I poisons. J. Med. Chem. 42, 446 (1999)   DOI   ScienceOn
4 Jain, A. N. : Surflex: fully automatic flexible molecular docking using a molecular similarity-based search engine. J. Med. Chem. 46, 499 (2003)   DOI   PUBMED   ScienceOn
5 Chrencik, J. E., Staker, B. L., Burgin, A. B., Pourquier, P., Pommier, Y., Stewart, L. and Redinbo, M. R. : Mechanisms of camptothecin resistance by human topoisomerase I mutations. J. Mol. Biol. 339, 773 (2004)   DOI   ScienceOn
6 Burke, T. G. and Bom, D. : Camptothecin design and delivery approaches for elevating anti-topoisomerase I activities in vivo. Ann. N. Y. Acad. Sci. 922, 36 (2000)   DOI   PUBMED   ScienceOn
7 Staker, B. L., Hjerrild, K., Feese, M. D., Behnke, C. A., Burgin, A. B., Jr. and Stewart, L. : The mechanism of topoisomerase I poisoning by a camptothecin analog. Proceedings of the National Academy of Sciences of the United States of America 99, 15387 (2002)   DOI   ScienceOn
8 Fox, B. M., Xiao, X., Antony, S., Kohlhagen, G., Pommier, Y., Staker, B. L., Stewart, L. and Cushman, M. : Design, synthesis, and biological evaluation of cytotoxic 11-alkenylindenoisoquinoline topoisomerase I inhibitors and indenoisoquinolinecamptothecin hybrids. J. Med. Chem. 46, 3275 (2003)   DOI   ScienceOn
9 Kohlhagen, G., Paull, K. D., Cushman, M., Nagafuji, P. and Pommier, Y. : Protein-linked DNA strand breaks induced by NSC 314622, a novel noncamptothecin topoisomerase I poison. Molecular Pharmacology 54, 50 (1998)   DOI   PUBMED
10 Jones, G., Willett, P., Glen, R. C., Leach, A. R. and Taylor, R. : Development and validation of a genetic algorithm for flexible docking. J. Mol. Biol. 267, 727 (1997)   DOI   ScienceOn
11 Jain, A. N. : Surflex-Dock 2.1: Robust performance from ligand energetic modeling, ring flexibility, and knowledge-based search. J. Comput. Aided Mol. Des. 21, 281 (2007)   DOI   PUBMED   ScienceOn
12 Cushman, M., Jayaraman, M., Vroman, J. A., Fukunaga, A. K., Fox, B. M., Kohlhagen, G., Strumberg, D. and Pommier, Y. : Synthesis of new indeno[1,2-c]isoquinolines: cytotoxic noncamptothecin topoisomerase I inhibitors. J. Med. Chem. 43, 3688 (2000)   DOI   ScienceOn
13 Pommier, Y. : Topoisomerase I inhibitors: camptothecins and beyond. Nature Reviews 6, 789 (2006)   DOI   PUBMED   ScienceOn
14 Marchand, C., Antony, S., Kohn, K. W., Cushman, M., Ioanoviciu, A., Staker, B. L., Burgin, A. B., Stewart, L. and Pommier, Y. : A novel norindenoisoquinoline structure reveals a common interfacial inhibitor paradigm for ternary trapping of the topoisomerase I-DNA covalent complex. Mol. Cancer. Ther. 5, 287 (2006)   DOI   ScienceOn
15 Staker, B. L., Feese, M. D., Cushman, M., Pommier, Y., Zembower, D., Stewart, L. and Burgin, A. B. : Structures of three classes of anticancer agents bound to the human topoisomerase I-DNA covalent complex. J. Med. Chem. 48, 2336 (2005)   DOI   ScienceOn
16 Brangi, M., Litman, T., Ciotti, M., Nishiyama, K., Kohlhagen, G., Takimoto, C., Robey, R., Pommier, Y., Fojo, T. and Bates, S. E. : Camptothecin resistance: role of the ATP-binding cassette (ABC), mitoxantrone-resistance half-transporter (MXR), and potential for glucuronidation in MXR-expressing cells. Cancer Research 59, 5938 (1999)   PUBMED
17 Pommier, Y. : Eukaryotic DNA topoisomerase I: genome gatekeeper and its intruders, camptothecins. Seminars in Oncology 23, 3 (1996)   PUBMED